-
1
-
-
0030610753
-
Baralyme® dehydration increases and soda lime dehydration decreases the concentration of compound A resulting from sevoflurane degradation in a standard anesthetic circuit
-
Eger EI, H, Ionescu P, Laster MJ, Weiskopf RB. Baralyme® dehydration increases and soda lime dehydration decreases the concentration of compound A resulting from sevoflurane degradation in a standard anesthetic circuit. Anesth Analg 1997;85: 892-8.
-
(1997)
Anesth Analg
, vol.85
, pp. 892-898
-
-
Eger II, E.I.1
Ionescu, P.2
Laster, M.J.3
Weiskopf, R.B.4
-
2
-
-
0037369619
-
Carbon monoxide production from sevoflurane breakdown: Modeling of exposures under clinical conditions
-
Holak EJ, Mei DA, Dunning MB III, et al. Carbon monoxide production from sevoflurane breakdown: modeling of exposures under clinical conditions. Anesth Analg 2003;96:757-64.
-
(2003)
Anesth Analg
, vol.96
, pp. 757-764
-
-
Holak, E.J.1
Mei, D.A.2
Dunning III, M.B.3
-
3
-
-
0023515511
-
Stability of 1-653 in soda lime
-
Eger EI, II. Stability of 1-653 in soda lime. Anesth Analg 1987; 66:983-5.
-
(1987)
Anesth Analg
, vol.66
, pp. 983-985
-
-
Eger II, E.I.1
-
4
-
-
0025843517
-
Clinical characteristics of desflurane in surgical patients: Minimum alveolar concentration
-
Rampil IJ, Lockhart S, Zwass M, et al. Clinical characteristics of desflurane in surgical patients: minimum alveolar concentration. Anesthesiology 1991;74:429-33.
-
(1991)
Anesthesiology
, vol.74
, pp. 429-433
-
-
Rampil, I.J.1
Lockhart, S.2
Zwass, M.3
-
5
-
-
0034804148
-
Age minimum alveolar anesthetic concentration, and minimum alveolar anesthetic concentration-awake
-
Eger EI, II. Age, minimum alveolar anesthetic concentration, and minimum alveolar anesthetic concentration-awake. Anesth Analg 2001;93:947-53.
-
(2001)
Anesth Analg
, vol.93
, pp. 947-953
-
-
Eger II, E.I.1
-
6
-
-
0016440017
-
Minimum alveolar concentrations (MAC) of isoflurane with and without nitrous oxide in patients of various ages
-
Stevens WC, Dolan WM, Gibbons RT et al. Minimum alveolar concentrations (MAC) of isoflurane with and without nitrous oxide in patients of various ages. Anesthesiology 1975;42: 197-200.
-
(1975)
Anesthesiology
, vol.42
, pp. 197-200
-
-
Stevens, W.C.1
Dolan, W.M.2
Gibbons, R.T.3
-
7
-
-
0018377856
-
Dragons and other scientific hazards
-
Eger EI, II. Dragons and other scientific hazards. Anesthesiology 1979;50:1.
-
(1979)
Anesthesiology
, vol.50
, pp. 1
-
-
Eger II, E.I.1
-
8
-
-
0032840475
-
The elimination of sodium and potassium hydroxides from desiccated soda lime diminishes degradation of desflurane to carbon monoxide and sevoflurane to compound A but does not compromise carbon dioxide absorption
-
Neumann MA, Laster MJ, Weiskopf RB, et al. The elimination of sodium and potassium hydroxides from desiccated soda lime diminishes degradation of desflurane to carbon monoxide and sevoflurane to compound A but does not compromise carbon dioxide absorption. Anesth Analg 1999;89:768-73.
-
(1999)
Anesth Analg
, vol.89
, pp. 768-773
-
-
Neumann, M.A.1
Laster, M.J.2
Weiskopf, R.B.3
-
9
-
-
0034115789
-
Absorbents differ enormously in their capacity to produce compound A and carbon monoxide
-
Stabernack CR, Brown R, Laster MJ, et al. Absorbents differ enormously in their capacity to produce compound A and carbon monoxide. Anesth Analg 2000;90:1428-35.
-
(2000)
Anesth Analg
, vol.90
, pp. 1428-1435
-
-
Stabernack, C.R.1
Brown, R.2
Laster, M.J.3
-
10
-
-
0032729443
-
Amsorb: A new carbon dioxide absorbent for use in anesthetic breathing systems
-
Murray JM, Renfrew CW, Bedi A, et al. Amsorb: a new carbon dioxide absorbent for use in anesthetic breathing systems. Anesthesiology 1999;91:1342-8.
-
(1999)
Anesthesiology
, vol.91
, pp. 1342-1348
-
-
Murray, J.M.1
Renfrew, C.W.2
Bedi, A.3
-
11
-
-
0029061488
-
Carbon monoxide production from degradation of desflurane, enflurane, isoflurane, halothane, and sevoflurane by soda lime and Baralyme®
-
Fang ZX, Eger EI, II, Laster MJ, et al. Carbon monoxide production from degradation of desflurane, enflurane, isoflurane, halothane, and sevoflurane by soda lime and Baralyme®. Anesth Analg 1995;80:1187-93.
-
(1995)
Anesth Analg
, vol.80
, pp. 1187-1193
-
-
Fang, Z.X.1
Eger II, E.I.2
Laster, M.J.3
-
12
-
-
0037360167
-
Sevoflurane degradation by carbon dioxide absorbents may produce more than one nephrotoxic compound in rats
-
Stabernack CR, Eger EI, II, Warnken UH, et al. Sevoflurane degradation by carbon dioxide absorbents may produce more than one nephrotoxic compound in rats. Can J Anaesth 2003;50: 249-52.
-
(2003)
Can J Anaesth
, vol.50
, pp. 249-252
-
-
Stabernack, C.R.1
Eger II, E.I.2
Warnken, U.H.3
-
13
-
-
0030965702
-
Rehydration of desiccated Baralyme prevents carbon monoxide formation from desflurane in an anesthesia machine
-
Baxter PJ, Kharasch ED. Rehydration of desiccated Baralyme prevents carbon monoxide formation from desflurane in an anesthesia machine. Anesthesiology 1997;86:1061-5.
-
(1997)
Anesthesiology
, vol.86
, pp. 1061-1065
-
-
Baxter, P.J.1
Kharasch, E.D.2
|